CRIS Current Research Information System

FERRACIN, MANUELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 10.579
NA - Nord America 10.226
EU - Europa 7.410
Continente sconosciuto - Info sul continente non disponibili 721
SA - Sud America 702
AF - Africa 513
OC - Oceania 19
Totale 30.170
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.992
CN - Cina 2.938
IT - Italia 2.637
VN - Vietnam 2.581
SG - Singapore 2.553
GB - Regno Unito 1.213
DE - Germania 826
HK - Hong Kong 698
SE - Svezia 527
BR - Brasile 492
IN - India 442
FR - Francia 426
RU - Federazione Russa 347
BD - Bangladesh 341
KR - Corea 298
NL - Olanda 250
IE - Irlanda 238
FI - Finlandia 195
ZA - Sudafrica 180
JP - Giappone 151
CA - Canada 128
UA - Ucraina 113
CH - Svizzera 105
CI - Costa d'Avorio 104
EE - Estonia 104
AR - Argentina 101
SC - Seychelles 90
HR - Croazia 87
ID - Indonesia 86
PK - Pakistan 84
TG - Togo 64
AT - Austria 63
EU - Europa 61
PH - Filippine 58
JO - Giordania 57
MX - Messico 54
ES - Italia 52
IQ - Iraq 52
PL - Polonia 50
TH - Thailandia 50
BG - Bulgaria 43
TR - Turchia 39
EC - Ecuador 34
TW - Taiwan 31
IR - Iran 26
BE - Belgio 23
GR - Grecia 23
CL - Cile 21
SA - Arabia Saudita 19
AU - Australia 17
CO - Colombia 14
UZ - Uzbekistan 14
CR - Costa Rica 13
JM - Giamaica 13
MA - Marocco 13
RO - Romania 13
DK - Danimarca 12
EG - Egitto 12
NG - Nigeria 12
PE - Perù 12
LT - Lituania 10
MY - Malesia 10
VE - Venezuela 10
CZ - Repubblica Ceca 9
KE - Kenya 8
LB - Libano 7
PY - Paraguay 7
UY - Uruguay 7
AE - Emirati Arabi Uniti 6
TN - Tunisia 6
DO - Repubblica Dominicana 5
DZ - Algeria 5
NP - Nepal 5
RS - Serbia 5
SI - Slovenia 5
AZ - Azerbaigian 4
BA - Bosnia-Erzegovina 4
BY - Bielorussia 4
ET - Etiopia 4
IL - Israele 4
MD - Moldavia 4
PT - Portogallo 4
SV - El Salvador 4
AL - Albania 3
HU - Ungheria 3
MN - Mongolia 3
OM - Oman 3
SM - San Marino 3
AM - Armenia 2
BB - Barbados 2
BH - Bahrain 2
BN - Brunei Darussalam 2
BO - Bolivia 2
CG - Congo 2
GA - Gabon 2
GM - Gambi 2
HN - Honduras 2
LV - Lettonia 2
MM - Myanmar 2
MQ - Martinica 2
Totale 29.468
Salva come PNG Salva come JPEG
Città #
Singapore 1.798
Ashburn 1.100
Fairfield 1.095
Southend 1.005
Bologna 722
Ho Chi Minh City 668
Hong Kong 652
San Jose 648
Hefei 580
Hanoi 527
Houston 511
Woodbridge 471
Seattle 461
Chandler 438
Wilmington 387
Cambridge 375
Ann Arbor 330
Beijing 303
Princeton 295
Seoul 272
Santa Clara 269
Boardman 259
Dublin 232
Dong Ket 217
Lauterbourg 197
Los Angeles 193
Dallas 172
Helsinki 153
Milan 150
Nanjing 138
Council Bluffs 135
New York 125
Berlin 124
Tokyo 120
Westminster 118
Rome 107
Abidjan 104
Frankfurt am Main 103
Padova 102
Da Nang 86
Buffalo 84
Redondo Beach 75
Haiphong 74
Shanghai 73
Bern 72
São Paulo 70
Jinan 69
Guangzhou 67
Lomé 64
Shenyang 64
Jakarta 62
San Diego 62
Saint Petersburg 59
Amman 57
Bengaluru 57
Johannesburg 57
Tianjin 55
Hebei 50
Changsha 48
Nuremberg 47
London 46
Olalla 46
Redmond 45
Chicago 44
Naples 41
Sofia 41
Amsterdam 39
Toronto 39
Zhengzhou 39
Nanchang 38
Phoenix 38
Des Moines 37
Munich 37
Turin 36
Florence 35
Rimini 35
Warsaw 35
Hangzhou 34
Vienna 34
Reggio Emilia 32
Bremen 31
Falls Church 30
Lappeenranta 30
Parma 30
Baghdad 29
Norwalk 29
Orem 29
Falkenstein 28
Modena 28
Brooklyn 26
Jacksonville 26
Shenzhen 26
Vicenza 26
Xi'an 26
Bangkok 24
Montreal 24
San Francisco 24
Wuhan 24
Boston 23
Ferrara 23
Totale 18.315
Salva come PNG Salva come JPEG
Nome #
Vaccine-Based Immunotherapy for Oropharyngeal and Nasopharyngeal Cancers 676
ARID1A in cancer: Friend or foe? 399
The Long Noncoding RNA CCAT2 Induces Chromosomal Instability Through BOP1-AURKB Signaling 375
Non-coding RNAs in disease: from mechanisms to therapeutics 344
CAR+ extracellular vesicles predict ICANS in patients with B cell lymphomas treated with CD19-directed CAR T cells 340
Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations 325
Exploring the Common Mutational Landscape in Cutaneous Melanoma and Pancreatic Cancer 288
Circulating microRNAs, MIR-939, MIR-595, MIR-519d and MIR-494, identify cirrhotic patients with HCC 288
DNA methylation of shelf, shore and open sea CpG positions distinguish high microsatellite instability from low or stable microsatellite status colon cancer stem cells 282
Synergic activity of FGFR2 and MEK inhibitors in the treatment of FGFR2-amplified cancers of unknown primary 271
MicroRNA and Metabolic Profiling of a Primary Ovarian Neuroendocrine Carcinoma Pulmonary-Type Reveals a High Degree of Similarity with Small Cell Lung Cancer 263
Metabolic profile evolution in relapsed/refractory B-cell non-Hodgkin lymphoma patients treated with CD19 chimeric antigen receptor T-cell therapy and implications in clinical outcome 254
Merkel Cell Carcinoma: An Updated Review Focused on Bone and Bone Marrow Metastases 251
MiR-494 induces metabolic changes through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma 244
Peripheral blood cellular profile at pre-lymphodepletion is associated with {CD}19-targeted {CAR}-T cell-associated neurotoxicity 240
Cancer of unknown primary: Challenges and progress in clinical management 240
MiR-30e-3p influences tumor phenotype through MDM2/TP53 axis and predicts sorafenib resistance in hepatocellular carcinoma 238
BRAF, KIT, and NRAS Mutations of Acral Melanoma in White Patients 234
Basal cell carcinoma: A comprehensive review 229
Genomic stability, anti-inflammatory phenotype, and up-regulation of the RNAseH2 in cells from centenarians 228
Impact of sialyltransferase ST6GAL1 overexpression on different colon cancer cell types 228
Pre-transplant CD69+ extracellular vesicles are negatively correlated with active ATLG serum levels and associate with the onset of GVHD in allogeneic HSCT patients 227
LncRNAs as novel players in hepatocellular carcinoma recurrence 226
Electrocardiogram analysis in Anderson-Fabry disease: a valuable tool for progressive phenotypic expression tracking 225
Case report: Senescence as mechanism of resistance to Pembrolizumab in a Lymphoma patient who failed CD19-Targeted CAR-T cell therapy 223
Exosomes from CD99-deprived Ewing sarcoma cells reverse tumor malignancy by inhibiting cell migration and promoting neural differentiation 221
Association of miR-146a-5p and miR-21-5p with Prognostic Features in Melanomas 218
A Systematic Review of Diagnostic and Prognostic Biomarkers for Head and Neck Cancer of Unknown Primary: An Unmet Clinical Need 217
Diagnostic and Prognostic Value of microRNAs in Patients with Laryngeal Cancer: A Systematic Review 216
ADK-VR2, a cell line derived from a treatment-naïve patient with SDC4-ROS1 fusion-positive primarily crizotinib-resistant NSCLC: a novel preclinical model for new drug development of ROS1- rearranged NSCLC 216
Serum from Advanced Heart Failure Patients Promotes Angiogenic Sprouting and Affects the Notch Pathway in Human Endothelial Cells 210
Circulating microRNA biomarkers in melanoma and non-melanoma skin cancer 210
The autocrine loop of ALK receptor and ALKAL2 ligand is an actionable target in consensus molecular subtype 1 colon cancer 207
Heterotopic auxiliary segment 2–3 liver transplantation with delayed total hepatectomy: New strategies for nonresectable colorectal liver metastases 206
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. 205
High Expression of the Sda Synthase B4GALNT2 Associates with Good Prognosis and Attenuates Stemness in Colon Cancer 203
Cancer site-specific multiple microRNA quantification by droplet digital PCR 200
Gastroesophageal circulating tumor cell crosstalk with peripheral immune system guides CTC survival and proliferation 199
MicroRNA-Based Prophylaxis in a Mouse Model of Cirrhosis and Liver Cancer 199
Combining gemcitabine and MSC delivering soluble TRAIL to target pancreatic adenocarcinoma and its stroma 195
The Sda synthase B4GALNT2 reduces malignancy and stemness in colon cancer cell lines independently of sialyl lewis X inhibition 195
Circulating MicroRNAs in Patients with Psoriasis Treated with Anti-IL-23: A Cohort Study 194
Cancer-associated rs6983267 SNP and its accompanying long noncoding RNA CCAT2 induce myeloid malignancies via unique SNP-specific RNA mutations 191
Unraveling the role of microRNA/isomiR network in multiple primary melanoma pathogenesis 191
Epigenetic and epitranscriptomic changes in colorectal cancer: diagnostic, prognostic, and treatment implications 190
MicroRNA profile in gastrointestinal stromal tumors (GISTs) and correlation with KIT/PDGFRA kinase genotype. 190
Circulating miR-184 is a potential predictive biomarker of cardiac damage in Anderson–Fabry disease 188
Correlations Between Cardiac Magnetic Resonance and Myocardial Histologic Findings in Fabry Disease 187
Circulating MicroRNA Quantification Using DNA-binding Dye Chemistry and Droplet Digital PCR 187
Genetic Characterization of Cancer of Unknown Primary Using Liquid Biopsy Approaches 186
Absolute quantification of cell-free microRNAs in cancer patients 182
Quantification of Circulating miRNAs by Droplet Digital PCR: Comparison of EvaGreen- and TaqMan-Based Chemistries. 180
Small extracellular vesicles deliver miR-21 and miR-217 as pro-senescence effectors to endothelial cells 180
Identification of miRNAs differentially expressed in human epilepsy with or without granule cell pathology 178
Combining anti-miR-155 with chemotherapy for the treatment of lung cancers 177
Estrogen Receptors and Melanoma: A Review 175
KRAS and ERBB-family genetic alterations affect response to PD-1 inhibitors in metastatic nonsquamous NSCLC 173
Integrating miRNA and gene expression profiling analysis revealed regulatory networks in gastrointestinal stromal tumors 172
MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality. 170
Interplay between small and long non-coding RNAs in cutaneous melanoma: a complex jigsaw puzzle with missing pieces 170
Association between gene and miRNA expression profiles and stereotyped subset #4 B-cell receptor in chronic lymphocytic leukemia 169
Cellular and Kaposi's sarcoma-associated herpes virus microRNAs in sepsis and surgical trauma. 169
Oncogenic role of miR-483-3p at the IGF2/483 locus. 164
MicroRNA profiling of primary pulmonary enteric adenocarcinoma in members from the same family reveals some similarities to pancreatic adenocarcinoma-a step towards personalized therapy 164
Essential role of MED1 in the transcriptional regulation of ER-dependent oncogenic miRNAs in breast cancer 163
Epigenetic age acceleration in hematopoietic stem cell transplantation 162
Non-coding RNA dysregulation in skin cancers 162
MiR-122/Cyclin G1 Interaction Modulates p53 Activity and Affects Doxorubicin Sensitivity of Human Hepatocarcinoma Cells. 159
MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis 159
Newly-discovered neural features expand the pathobiological knowledge of blastic plasmacytoid dendritic cell neoplasm 158
Circulating microRNAs and isomiRs as biomarkers for the initial insult and epileptogenesis in four experimental epilepsy models: The EPITARGET study 157
Increase of microRNA-210, decrease of raptor gene expression and alteration of mammalian target of rapamycin regulated proteins following mithramycin treatment of human erythroid cells 156
CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer 156
Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model 155
Circulating non-coding RNA as biomarkers in colorectal cancer 153
Predictive Factors for Sentinel Lymph Node Positivity in Melanoma Patients—The Role of Liquid Biopsy, MicroRNA and Gene Expression Profile Panels 152
Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T cells in chronic hepatitis B 152
Involvement of the inconstant bursa of the fifth metatarsophalangeal joint in psoriatic arthritis: A clinical and ultrasonographic study 150
Non-coding RNAs as predictive biomarkers to current treatment in metastatic colorectal cancer 150
Sickle Cell Trait and SARS-CoV-2-Induced Rhabdomyolysis: A Case Report 150
Anti-CD38 antibody therapy: windows of opportunity yielded by the functional characteristics of the target molecule. 149
Surfaces environmental monitoring of SARS-CoV-2: Loop mediated isothermal amplification (LAMP) and droplet digital PCR (ddPCR) in comparison with standard Reverse-Transcription quantitative polymerase chain reaction (RT-qPCR) techniques 147
Differential cytogenomics and miRNA signature of the Acute Myeloid Leukaemia Kasumi-1 cell line CD34+38- compartment 145
Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma: A validation across two independent cohorts 144
Defining the Prognostic Role of MicroRNAs in Cutaneous Melanoma 144
MicroRNA dysregulation in ataxia telangiectasia 143
MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia 143
First report of circulating microRNAs in tumour necrosis factor receptor-associated periodic syndrome (TRAPS). 143
MicroRNA expression profiling with a droplet digital PCR assay enables molecular diagnosis and prognosis of cancers of unknown primary 143
Altered miRNA expression in T regulatory cells in course of multiple sclerosis. 141
A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia 140
Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs 140
Quantification of circulating micrornas by droplet digital PCR 140
MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma. 139
miR-126&126* Restored Expressions Play a Tumor Suppressor Role by Directly Regulating ADAM9 and MMP7 in Melanoma 138
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients. 138
MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias 138
Decreased serum levels of the inflammaging marker miR-146a are associated with non-clinical response to tocilizumab in COVID-19 patients 138
Defining high-risk patients: beyond the 8the AJCC melanoma staging system 137
Altered expression of selected microRNAs in melanoma: antiproliferative and proapoptotic activity of miRNA-155. 136
Totale 19.902
Salva come PNG Salva come JPEG
Categoria #
all - tutte 85.493
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 85.493
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.397 0 124 196 190 222 163 96 223 108 193 438 444
2022/20232.518 250 322 122 314 147 174 103 145 430 69 231 211
2023/20241.055 101 144 83 104 76 124 77 71 51 71 75 78
2024/20254.856 155 647 473 298 468 246 614 240 112 334 389 880
2025/202611.893 952 1.599 1.099 871 1.036 544 1.126 414 2.261 724 667 600
2026/2027491 487 4 0 0 0 0 0 0 0 0 0 0
Totale 30.170